Form 4: Pediatrix Executive Reports Stock Transaction
Statement of Changes in Beneficial Ownership
Pediatrix Medical Group, Inc. executive Mary Ann E. Moore reported a transaction involving common stock, including shares withheld for tax payments.
Summary
- Mary Ann E. Moore, EVP, GC, Chief Admin Off & Sec at Pediatrix Medical Group, Inc., reported a transaction on June 1, 2026.
- 11,944 shares of common stock were acquired and withheld for the payment of taxes upon vesting.
- The transaction price was $21.54 per share.
- Following this transaction, Ms. Moore beneficially owns 96,466 shares of common stock directly.
- Additionally, 93,424 shares are held indirectly by a trust where Ms. Moore and her spouse are trustees.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction for tax purposes and does not indicate a change in the executive's overall beneficial ownership or outlook on the company.
Positives
- The executive continues to hold a significant number of shares, indicating continued commitment to the company.
- The withholding of shares for tax payment upon vesting is a standard and expected practice.
Negatives
- The filing details a transaction where shares were withheld, which could be interpreted as a reduction in direct holdings, though it's for tax purposes.
Future Outlook
No specific forward-looking statements or guidance were provided in this Form 4 filing.
Management Comments
- The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for executives and directors regarding their company stock transactions. This filing by a Pediatrix Medical Group executive is typical for reporting share withholdings related to vesting and tax obligations, providing transparency on insider holdings.
Stakeholder Impact
- Shareholders: Increased transparency regarding executive stock holdings and transactions.
- Employees: Standard practice related to executive compensation and equity awards.
- Management: Routine compliance with SEC reporting requirements.
Key Dates
| Date | Description |
|---|---|
| 06/01/2026 | Transaction Date for common stock acquisition and tax withholding. |
| 06/03/2026 | Date of signature for the filing. |
Keywords
Pediatrix Medical Group, MD, Form 4, Insider Transaction, Stock Withholding, Beneficial Ownership, Mary Ann E. Moore, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.